Telix Pharmaceuticals Limited (ASX:TLX)
25.87
-0.45 (-1.71%)
Apr 16, 2025, 4:10 PM AEST
Telix Pharmaceuticals Employees
Telix Pharmaceuticals had 234 employees as of December 31, 2022. The number of employees increased by 76 or 48.10% compared to the previous year.
Employees
234
Change (1Y)
76
Growth (1Y)
48.10%
Revenue / Employee
1.85M AUD
Profits / Employee
118.01K AUD
Market Cap
8.89B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 234 | 76 | 48.10% |
Dec 31, 2021 | 158 | 149 | 1,655.56% |
Dec 31, 2017 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 32,698 |
Cochlear | 5,097 |
Sonic Healthcare | 42,000 |
Ramsay Health Care | 90,000 |
Ansell | 15,000 |
Mesoblast | 73 |
Regis Healthcare | 11,000 |
Nanosonics | 466 |
Telix Pharmaceuticals News
- 13 hours ago - IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate - GlobeNewsWire
- 8 days ago - Telix Announces Cardinal Health for Gozellix Commercial Distribution - GlobeNewsWire
- 8 days ago - Five Below, Telix Pharmaceuticals, Dollar Tree And Other Big Stocks Moving Higher On Monday - Benzinga
- 8 days ago - Telix Pharmaceuticals gets new technology chief - Seeking Alpha
- 9 days ago - Telix Appoints Paul Schaffer as Chief Technology Officer - GlobeNewsWire
- 11 days ago - Telix Pharmaceuticals: Building A Radiopharma Powerhouse - Seeking Alpha
- 12 days ago - Anne Whitaker Appointed as Non-Executive Director - GlobeNewsWire
- 14 days ago - Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma - GlobeNewsWire